COVID Vaccines Approved 5-11 years

On November 2, the CDC ACIP voted to recommend the use of Pfizer BioNTech’s COVID vaccine for children 5-11 years under an emergency use authorization of the FDA.       We understand that a spectrum of feelings toward this vaccine exist.   We have reviewed the available information and find that the data supports offering children aged 5-11 vaccination.   The risk-benefit proposition in this age group is similar to influenza vaccination and other rare but serious infections.  However, we recommend … Continue reading COVID Vaccines Approved 5-11 years